NCT02854969
Completed
Not Applicable
Randomized, Cross-over, Open, Unicentric Trial Evaluating Satisfaction With the Use of a Medical Device for the Epinephrine Auto-injector in Patients With Anaphylaxis
ConditionsAnaphylaxis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Anaphylaxis
- Sponsor
- Adan Medical Innovation, SL
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Patient satisfaction through a questionnaire in the use of the medical device
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Through several questionaries the investigators will measure the satisfaction of patients diagnosed with anaphylaxis in the use of a medical device for the adrenaline autoinjector, a smart case for an epinephrine autoinjector connected via Bluetooth to a mobile application.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients 18 years old or above
- •Patients diagnosed with Anaphylaxis and an epinephrine auto-injector prescribed
- •Patients with a smartphone
- •Patients who signed the informed consent
Exclusion Criteria
- •Patients who have not signed the informed consent
- •Patients with some limitations for understanding or following correctly the trial procedures
- •Pregnant or nursing women
Outcomes
Primary Outcomes
Patient satisfaction through a questionnaire in the use of the medical device
Time Frame: 3 months
Secondary Outcomes
- Medical device safety(3 months)
- Patient Adherence to the medical device through a questionnaire(3 months)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 4
Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar LinesGlabellar LinesWrinklesNCT02718118Galderma R&D60
Completed
Not Applicable
Vivity Insight: A Study of Patient Satisfaction and Visual PerformanceCataractNCT04495049Research Insight LLC60
Completed
Not Applicable
Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)Head and Neck Squamous Cell CarcinomaColorectal CancerNon Small Cell Lung CancerEpidermal Growth Factor Receptor InhibitorNCT03421912Centre Leon Berard102
Completed
Not Applicable
Avonex PEN Satisfaction and Patients Experience Clinical TrialMultiple SclerosisNCT01366040Biogen89
Completed
Phase 3
PET/MRI in Patients With Suspected Prostate CancerProstate CancerNCT02659527Medical University of Vienna220